Can you identify the latest developments related to the treatment of blood cancers? Test your knowledge.
Can you identify the latest developments related to the treatment of blood cancers? Test your knowledge.
Correct Answer and Next Question
ANSWER: B. Increased significantly
Correct Answer and Next Question
ANSWER: D. All of the above
Correct Answer and Next Question
Answer: A. Has been approved by the FDA for selected applications in treating blood cancer
Correct Answer and Next Question
ANSWER: C. Side effects tend to be more severe than with standard therapy
Correct Answer and Next Question
ANSWER: B. Adult Hodgkin lymphoma
Correct Answer and Next Question
ANSWER: B. Home care
Correct Answer and Next Question
ANSWER: D. All of the above
Correct Answer and Next Question
ANSWER: C. A patient is diagnosed with non-Hodgkin lymphoma: 66,769 people diagnosed with non-Hodgkin lymphoma in 2104 --the most recent year for which numbers are available-versus 8,581 with Hodgkin lymphoma. Deaths: 20,387 from non-Hodgkin lymphoma; 1,077 from Hodgkin lymphoma).
Correct Answer and Next Question
ANSWER: C. 75%
Correct Answer and Next Question
ANSWER: A. Acute myeloid leukemia (AML)
Correct Answer and Next Question
ANSWER: D. Both A and B
ANSWER: D. All of the above
Sources: Unless otherwise noted, information was taken from public domains such as the National Cancer Institute and the CDC.
Prevention Could Cut Global Cancer Deaths in Half
June 30th 2025According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and breast cancer incidence due to increasing adoption of behaviors associated with economic development—such as tobacco use, poor nutrition and physical inactivity.
Read More
Attacking PRPS Enzymes Offers Hope for Treating Fast-Growing Myc-Driven Lymphomas
June 10th 2025Researchers found that altering key enzymes involved in redox balance could disrupt the metabolism of Myc-driven lymphomas, which offers a potential new strategy to treat aggressive cancers.
Read More
Using the 'Pathway' Approach to Shorten the Time Between Cancer Diagnosis and Treatment
November 16th 2022In this episode of Tuning In to the C-Suite, Briana Contreras, editor with Managed Healthcare Executive spoke with Dr. Yuri Fesko, oncologist and vice president of Medical Affairs at Quest Diagnostics. In the conversation, Dr. Fesko addressed the ongoing issue of long gaps of times between receiving a diagnosis for a type of cancer and finally getting the treatment for it. Dr. Fesko shared the benefits a number of sectors receive when treating patients sooner and the steps to get there.
Listen
The First Financial Toxicity Tumor Board Reports Success in Individual Patient Savings
May 14th 2025Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications to save money, or they may incur high medical debt or go into bankruptcy to pay for medical care.
Read More
Survey Reveals Cancer Doctors Struggle to Keep Up as Treatments Advance Quickly
May 11th 2025A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, with many calling for better tools, education and collaboration to help integrate new treatments and technologies into everyday practice.
Read More